Elias Reichel, MD
Hemera Biosciences/ New England Eye Center
Dr. Reichel is a founder of Hemera Biosciences, a clinical-stage start-up developing a gene therapy for age-related macular degeneration. He is Professor and Vice Chair and Director of the Vitreoretinal Service at the New England Eye Center in Boston. He serves as a consultant and advisor to biotechnology, pharmaceutical and device companies and has developed laser technologies, devices and drugs for the ophthalmic market.
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.